{"count": 2, "results": [{"_id": "34987247", "pmid": 34987247, "title": "Selected Antihypertensive Agents and Their Fixed-Dose Combinations Effectively Ameliorate Trastuzumab-Mediated Cardiac Dysfunction In Rats.", "journal": "Niger J Physiol Sci", "authors": ["Adeneye AA", "Olorundare OE", "Omobowale TO", "Akinsola AO", "Kolo PM", "Albrecht RMA", "Crooks PA"], "date": "2021-06-30T00:00:00Z", "meta_date_publication": "2021 Jun 30", "meta_volume": "36", "meta_issue": "1", "meta_pages": "57-65", "score": 50235.164, "text_hl": "This study evaluates the therapeutic potentials of selected antihypertensive drugs [@CHEMICAL_Valsartan @CHEMICAL_MESH:D000068756 @@@valsartan@@@, @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and their fixed-dose combinations (@CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@ + @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@) and (@CHEMICAL_Valsartan @CHEMICAL_MESH:D000068756 @@@valsartan@@@ + @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@)] in ameliorating @CHEMICAL_Trastuzumab @CHEMICAL_MESH:D000068878 @@@trastuzumab@@@ (@CHEMICAL_Trastuzumab @CHEMICAL_MESH:D000068878 @@@TZM@@@)-induced @DISEASE_Heart_Diseases @DISEASE_MESH:D006331 @@@cardiac dysfunctions@@@ in experimental @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Adeneye AA, Olorundare OE, Omobowale TO, Akinsola AO, Kolo PM, Albrecht RMA, Crooks PA. Selected Antihypertensive Agents and Their Fixed-Dose Combinations Effectively Ameliorate Trastuzumab-Mediated Cardiac Dysfunction In Rats. Niger J Physiol Sci. 2021 Jun 30;36(1):57-65. PMID: 34987247", "BibTeX": "@article{34987247, title={Selected Antihypertensive Agents and Their Fixed-Dose Combinations Effectively Ameliorate Trastuzumab-Mediated Cardiac Dysfunction In Rats.}, author={Adeneye AA and Olorundare OE and Omobowale TO and Akinsola AO and Kolo PM and Albrecht RMA and Crooks PA}, journal={Niger J Physiol Sci}, volume={36}, number={1}, pages={57-65}}"}}, {"_id": "19344651", "pmid": 19344651, "title": "ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.", "journal": "Vascul Pharmacol", "authors": ["Sacco G", "Mario B", "Lopez G", "Evangelista S", "Manzini S", "Maggi CA"], "date": "2009-05-01T00:00:00Z", "doi": "10.1016/j.vph.2009.01.001", "meta_date_publication": "2009 May-Jun", "meta_volume": "50", "meta_issue": "5-6", "meta_pages": "166-70", "score": 50049.223, "text_hl": "Using dose levels (0.1 mg/kg/day and 10 mg/kg/day) which inhibits partially (about 50%) or almost totally (about 80%) serum @GENE_ACE @GENE_24310 @@@angiotensin converting enzyme@@@, we evaluated the effects of @CHEMICAL_zofenopril @CHEMICAL_MESH:C044958 @@@zofenopril@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ in preventing @DISEASE_Heart_Neoplasms @DISEASE_MESH:D006338 @@@cardiac alterations@@@ (@<m>DISEASE_Long_QT_Syndrome</m> @DISEASE_MESH:D008133 @@@QalphaT prolongation@@@) induced by chronic treatment with @CHEMICAL_Doxorubicin @CHEMICAL_MESH:D004317 @@@doxorubicin@@@ (1.5 mg/kg q7dx5 i.v.). ", "citations": {"NLM": "Sacco G, Mario B, Lopez G, Evangelista S, Manzini S, Maggi CA. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat. Vascul Pharmacol. 2009 May-Jun;50(5-6):166-70. PMID: 19344651", "BibTeX": "@article{19344651, title={ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.}, author={Sacco G and Mario B and Lopez G and Evangelista S and Manzini S and Maggi CA}, journal={Vascul Pharmacol}, volume={50}, number={5-6}, pages={166-70}}"}}]}